are generic glp 1 safe GLP-1 Medications Safe? PlexusDx Guide GLP-1 Safety Check - National

In phase 3 trials, maximal dose retatrutide demonstrated 29% placebo-adjusted weight loss at 68 weeks (albeit with higher discontinuation rates than semaglutide and tirzepatide)

These long-term exposures have been associated with a variety of systemic effects (mycotoxicoses) in both humans and animals and most commonly manifest as nephrotoxicity, hepatotoxicity, immunosuppression, carcinogenicity, and teratogenicity

Jpn J Clin Oncol (2008) 38(4):30816.10.1093/jjco/hyn007 285 JenkinsPJMukherjeeAShaletSM

Research preparations require appropriate reconstitution and storage protocols to maintain the stability and biological activity of both peptide components